
Study: Vision Impairment Signals Linked to Semaglutide Use
As the use of semaglutide (Ozempic, Wegovy; Novo Nordisk) has increased in managing type 2 diabetes (T2D) and obesity, researchers have raised concerns about a potential link with ocular impairments. To help address these concerns, investigators conducted …